Label (71610 0946 30)
Pregabalin Capsule
Product Images NDC 71610-946
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Chemical Structure (Pregabalin 01)
Figure 1 (Pregabalin 02)
Figure 2 (Pregabalin 03)
Figure 3 (Pregabalin 04)
Figure 4 (Pregabalin 05)
This text provides data related to patient improvement rates based on different treatment regimens. The study compares the efficacy of Pregabalin in doses of 200 mg three times a day, 100 mg three times a day, and a placebo. The graph shows the percentage of patients experiencing improvement in pain from baseline after receiving the respective treatments.*
Figure 5 (Pregabalin 06)
Figure 6 (Pregabalin 07)
Figure 7 (Pregabalin 08)
Figure 8 (Pregabalin 09)
This text provides information on responder rates for different doses in a study, including percentages for placebo and two dose levels (2.5 mg/kg/day and 10 mg/kg/day). The responder rates for each dose level are given in percentages, with the highest responder rate being 40.6%.*
Figure 9 (Pregabalin 10)
Figure 10 (Pregabalin 11)
Figure 11 (Pregabalin 12)
Percent of Subjects improved from Baseline to Week 12 under Pregabalin treatment. The values range from 20 to 280, with the highest percentage being 100.*
Figure 12 (Pregabalin 13)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
